about
Inflammatory bowel disease in Asia: A systematic reviewFrequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancerWarburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesisPhosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammationSystematic review: the efficacy of herbal therapy in inflammatory bowel diseaseQuestionnaire-Based Survey on Diagnostic and Therapeutic Endoscopies and H. pylori Eradication for Elderly Patients in East Asian CountriesManagement of high-risk patients on non-steroidal anti-inflammatory drugs or aspirinNSAID-induced peptic ulcers and Helicobacter pylori infection: implications for patient managementShould we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?Drug-induced side effects affecting the gastrointestinal tractSmall bowel enteropathy associated with chronic low-dose aspirin therapyHaemoglobin decreases in NSAID users over time: an analysis of two large outcome trialsmicroRNA-139-5p exerts tumor suppressor function by targeting NOTCH1 in colorectal cancerEpigenomic and Functional Characterization of Junctophilin 3 (JPH3) as a Novel Tumor Suppressor Being Frequently Inactivated by Promoter CpG Methylation in Digestive Cancers.Role of acid suppressants in prophylaxis of NSAID damage.Hydrogen sulfide lowers proliferation and induces protective autophagy in colon epithelial cells.Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.microRNA-221 and microRNA-18a identification in stool as potential biomarkers for the non-invasive diagnosis of colorectal carcinoma.MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancerCelecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial.The knowledge of colorectal cancer symptoms and risk factors among 10,078 screening participants: are high risk individuals more knowledgeable?Tumor suppressor functions of miR-133a in colorectal cancer.Perceived obstacles of colorectal cancer screening and their associated factors among 10,078 Chinese participantsOncogenic induction of cellular high CpG methylation by Epstein-Barr virus in malignant epithelial cellsEnvironmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific.Survey of clinical practice for irritable bowel syndrome in East asian countries.COX-2 inhibition, H. pylori infection and the risk of gastrointestinal complications.Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis.Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.Esophageal bleeding disorders.The discriminatory capability of existing scores to predict advanced colorectal neoplasia: a prospective colonoscopy study of 5,899 screening participants.Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer.MicroRNA-20a in human faeces as a non-invasive biomarker for colorectal cancerIncreased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer.Fibulin 1 is downregulated through promoter hypermethylation in gastric cancerAsia-Pacific consensus on the management of gastroesophageal reflux disease: update.Asia Pacific consensus recommendations for colorectal cancer screening.Identification of retinoic acid-regulated nuclear matrix-associated protein as a novel regulator of gastric cancer.Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients--a longitudinal observational study.Nonsteroid anti-inflammatory drug-induced gastroduodenal injury.
P50
Q22242420-D47D30EE-65F0-47A4-82FE-227701C6FB14Q24293304-C14B0ADD-A8A4-4591-83DC-78CE7A6314FDQ24313608-946ED33D-182D-4405-BE2B-800D55C0B8D5Q24338129-F4DCA921-C26D-41B9-B87D-9BA75EC95C68Q27004516-F0460629-BA60-4F1D-8951-93C202461241Q28068932-2D45F21E-0075-43F5-B21A-22FC5F18E09EQ28199776-92DBB410-E5BB-4EF1-BEA5-50D94B11BF4AQ28211155-D6C79AF5-1E6C-4A78-9DEF-145AE97C9C1BQ28213638-51FCBAF5-CAC3-4B4A-9FD9-BA0B2A52A0AFQ28219073-37ACE623-96DA-47F4-8464-A6CCA2DDA919Q28219150-CCF0D684-ABBA-4221-A3DB-B3D03B08E35CQ30430170-15212E6C-2509-4F74-93C4-F83DCB2FE23AQ33784290-AB724298-D1D2-45A7-A866-58ADB77C9BA9Q33836449-6488AB7A-EB56-4752-8ECD-867D3E6F6121Q34279898-FECD4A3B-3D2A-463E-BA50-6FEA35070670Q34297044-EEF29DC1-A4D6-4675-BBB4-03E81B23B92DQ34424883-C33ACDB0-806C-444B-87AB-E9DB6F80CCC0Q34439377-C2787A0F-BB93-43A4-8EA4-E57CC87C9B2AQ34599928-C97FAF08-ECBD-4268-B174-5E490100C46FQ34621619-D2FFC626-6531-4444-9189-C2B1D907A1AFQ34661921-91FF4EA8-8560-41CE-B7B4-B28A1765709AQ34748993-BA2059FE-F0B2-4427-934A-17511AD20859Q34875771-3DDB964A-1AF2-4564-9A39-193C59BB4F14Q35020438-79583F6C-6D9E-4774-ADF3-993338719B36Q35250967-3199DB03-BF5C-4E2F-8463-2D60BEE8440DQ35551272-703F9F45-D3B9-4BF3-BB6A-EBFE9F136A81Q35551916-A7FE6237-895B-479A-A5C1-AB2F260820A3Q35867272-B721054F-FFD7-47F9-9BF1-30BAF9E47BEFQ36001198-1F456C85-4CF7-4502-888F-CE0FE92BECCFQ36036606-0ADED489-9F3C-4328-A32C-20A2D8AF85FEQ36536151-FC4F91A3-6D97-4741-947C-0DCA20757233Q36622560-D52EAC3B-AA9D-44A5-ADE3-3600DDF76B2AQ36738904-A1AE4E0F-CDBA-4ED5-A337-DE7835379860Q36761921-AE8ABF45-959D-481A-9783-5AF1F8E44A8EQ37023915-FAD86292-B663-49B8-AA89-749840D0457DQ37048727-E424CC00-BD2E-497B-A466-EDB9DE3FF59BQ37217101-49B24FBC-38B7-4E94-B116-2BB75D2C8122Q37330694-E2C0AE56-AEBF-4D08-BFD9-3D9C29D3C0DEQ37420541-C44850D3-C49E-494C-84BD-3E5C32ADD328Q37583482-82C73E1E-44EC-4898-AA76-E5AEF9C9EB69
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Francis Ka-Ming Chan
@ast
Francis Ka-Ming Chan
@en
Francis Ka-Ming Chan
@es
Francis Ka-Ming Chan
@nl
Francis Ka-Ming Chan
@sl
type
label
Francis Ka-Ming Chan
@ast
Francis Ka-Ming Chan
@en
Francis Ka-Ming Chan
@es
Francis Ka-Ming Chan
@nl
Francis Ka-Ming Chan
@sl
prefLabel
Francis Ka-Ming Chan
@ast
Francis Ka-Ming Chan
@en
Francis Ka-Ming Chan
@es
Francis Ka-Ming Chan
@nl
Francis Ka-Ming Chan
@sl
P1006
P214
P244
P1006
P1053
F-4851-2010
P106
P1153
35725083400
55512627500
P21
P213
0000 0000 6514 9413
P214
P244
nb2009018232
P31
P3829
P496
0000-0001-7388-2436
P5008
P735
P7859
lccn-nb2009018232